Phase II Study of SU011248 in Men With Advanced Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2012
At a glance
- Drugs Sunitinib (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 11 Feb 2009 Actual end date changed from Jun 2007 to Jun 2008 as reported by ClinicalTrials.gov.
- 16 Nov 2007 New trial record.